BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 27639802)

  • 1. Fucosylation Deficiency in Mice Leads to Colitis and Adenocarcinoma.
    Wang Y; Huang D; Chen KY; Cui M; Wang W; Huang X; Awadellah A; Li Q; Friedman A; Xin WW; Di Martino L; Cominelli F; Miron A; Chan R; Fox JG; Xu Y; Shen X; Kalady MF; Markowitz S; Maillard I; Lowe JB; Xin W; Zhou L
    Gastroenterology; 2017 Jan; 152(1):193-205.e10. PubMed ID: 27639802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretory cell hyperplasia and defects in Notch activity in a mouse model of leukocyte adhesion deficiency type II.
    Waterhouse CC; Johnson S; Phillipson M; Zbytnuik L; Petri B; Kelly M; Lowe JB; Kubes P
    Gastroenterology; 2010 Mar; 138(3):1079-90.e1-5. PubMed ID: 19900444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cloning and expression of GDP-D-mannose-4,6-dehydratase, a key enzyme for fucose metabolism defective in Lec13 cells.
    Ohyama C; Smith PL; Angata K; Fukuda MN; Lowe JB; Fukuda M
    J Biol Chem; 1998 Jun; 273(23):14582-7. PubMed ID: 9603974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notch-Regulated Dendritic Cells Restrain Inflammation-Associated Colorectal Carcinogenesis.
    Wang L; Yu S; Chan ER; Chen KY; Liu C; Che D; Awadallah A; Myers J; Askew D; Huang AY; Maillard I; Huang D; Xin W; Zhou L
    Cancer Immunol Res; 2021 Mar; 9(3):348-361. PubMed ID: 33441309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conditional control of selectin ligand expression and global fucosylation events in mice with a targeted mutation at the FX locus.
    Smith PL; Myers JT; Rogers CE; Zhou L; Petryniak B; Becker DJ; Homeister JW; Lowe JB
    J Cell Biol; 2002 Aug; 158(4):801-15. PubMed ID: 12186857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Colon Tumors Express a Dominant-Negative Form of SIGIRR That Promotes Inflammation and Colitis-Associated Colon Cancer in Mice.
    Zhao J; Bulek K; Gulen MF; Zepp JA; Karagkounis G; Martin BN; Zhou H; Yu M; Liu X; Huang E; Fox PL; Kalady MF; Markowitz SD; Li X
    Gastroenterology; 2015 Dec; 149(7):1860-1871.e8. PubMed ID: 26344057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines.
    Noda K; Miyoshi E; Gu J; Gao CX; Nakahara S; Kitada T; Honke K; Suzuki K; Yoshihara H; Yoshikawa K; Kawano K; Tonetti M; Kasahara A; Hori M; Hayashi N; Taniguchi N
    Cancer Res; 2003 Oct; 63(19):6282-9. PubMed ID: 14559815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
    He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
    Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of GDP-L-fucose by the human FX protein.
    Tonetti M; Sturla L; Bisso A; Benatti U; De Flora A
    J Biol Chem; 1996 Nov; 271(44):27274-9. PubMed ID: 8910301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell lines expressing mutant FX proteins to generate proteins with reduced rate of fucosylation: WO2010/141478.
    Taupin P
    Expert Opin Ther Pat; 2011 Jul; 21(7):1143-6. PubMed ID: 21554153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Alkynyl-Fucose Halts Hepatoma Cell Migration and Invasion by Inhibiting GDP-Fucose-Synthesizing Enzyme FX, TSTA3.
    Kizuka Y; Nakano M; Yamaguchi Y; Nakajima K; Oka R; Sato K; Ren CT; Hsu TL; Wong CH; Taniguchi N
    Cell Chem Biol; 2017 Dec; 24(12):1467-1478.e5. PubMed ID: 29033318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of genes that control core fucosylation in hepatocellular carcinoma: Systematic review.
    Norton PA; Mehta AS
    World J Gastroenterol; 2019 Jun; 25(23):2947-2960. PubMed ID: 31249452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Free Fatty Acid Receptor 2 by Dendritic Cells Prevents Their Expression of Interleukin 27 and Is Required for Maintenance of Mucosal Barrier and Immune Response Against Colorectal Tumors in Mice.
    Lavoie S; Chun E; Bae S; Brennan CA; Gallini Comeau CA; Lang JK; Michaud M; Hoveyda HR; Fraser GL; Fuller MH; Layden BT; Glickman JN; Garrett WS
    Gastroenterology; 2020 Apr; 158(5):1359-1372.e9. PubMed ID: 31917258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FX enzyme and GDP-L-Fuc transporter expression in colorectal cancer.
    Villar-Portela S; Muinelo-Romay L; Cuevas E; Gil-Martín E; Fernández-Briera A
    Histopathology; 2013 Aug; 63(2):174-86. PubMed ID: 23730929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional expression of Escherichia coli enzymes synthesizing GDP-L-fucose from inherent GDP-D-mannose in Saccharomyces cerevisiae.
    Mattila P; Räbinä J; Hortling S; Helin J; Renkonen R
    Glycobiology; 2000 Oct; 10(10):1041-7. PubMed ID: 11030750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of GDP-4-keto-6-deoxymannose-3,5-epimerase-4-reductase with GDP-mannose-4,6-dehydratase stabilizes the enzyme activity for formation of GDP-fucose from GDP-mannose.
    Nakayama K; Maeda Y; Jigami Y
    Glycobiology; 2003 Oct; 13(10):673-80. PubMed ID: 12881408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enteric Delivery of Regenerating Family Member 3 alpha Alters the Intestinal Microbiota and Controls Inflammation in Mice With Colitis.
    Darnaud M; Dos Santos A; Gonzalez P; Augui S; Lacoste C; Desterke C; De Hertogh G; Valentino E; Braun E; Zheng J; Boisgard R; Neut C; Dubuquoy L; Chiappini F; Samuel D; Lepage P; Guerrieri F; Doré J; Bréchot C; Moniaux N; Faivre J
    Gastroenterology; 2018 Mar; 154(4):1009-1023.e14. PubMed ID: 29133078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TSTA3 facilitates esophageal squamous cell carcinoma progression through regulating fucosylation of LAMP2 and ERBB2.
    Zhang L; Gao Y; Zhang X; Guo M; Yang J; Cui H; Kong P; Niu X; Bi Y; Xu J; Yan T; Ma Y; Yang J; Qian Y; Wang F; Li H; Liu F; Cheng X; Cui Y
    Theranostics; 2020; 10(24):11339-11358. PubMed ID: 33042286
    [No Abstract]   [Full Text] [Related]  

  • 19. Eriodictyol suppresses the malignant progression of colorectal cancer by downregulating tissue specific transplantation antigen P35B (TSTA3) expression to restrain fucosylation.
    Huang H; He Y; Li Y; Gu M; Wu M; Ji L
    Bioengineered; 2022 Mar; 13(3):5551-5563. PubMed ID: 35184647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of FX
    Liu W; Padmashali R; Monzon OQ; Lundberg D; Jin S; Dwyer B; Lee YJ; Korde A; Park S; Pan C; Zhang B
    Biotechnol Prog; 2021 Jan; 37(1):e3061. PubMed ID: 32748555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.